Lassa virus genomic surveillance is becoming increasingly critical as exported cases of this zoonotic arenavirus rise globally. Researchers have developed new open-access resources on the Nextstrain and Nextclade platforms to support real-time outbreak responses. These innovative tools help clinicians and public health officials track viral evolution more effectively across West Africa and other regions.

The Nextstrain and Nextclade platforms now offer tailored builds specifically for the Lassa virus (LASV). These systems analyze both the L and S segments of the viral genome. Furthermore, they provide rapid mutation detection and precise lineage assignment. Consequently, this enhances the capacity to monitor seasonal epidemics and improves our readiness for potential outbreaks.

Advancing Lassa Virus Genomic Surveillance and Lineage Assignment

A dedicated phylogeny of the glycoprotein complex (GPC) allows for the tracking of clinically significant mutations. For instance, the A76 variant in lineage II is particularly noteworthy for researchers. This mutation is implicated in the reduced binding efficacy of monoclonal antibody 25.10C. Therefore, having access to such genomic data is vital for guiding clinical decision-making and informing future immunotherapy development.

Despite these technical advancements, significant challenges in data collection persist. There is currently an average two-year delay between sample collection and genomic data submission. Furthermore, limited resources and the fear of political repercussions often restrict data sharing in endemic regions. However, addressing these disparities is essential for maintaining a robust global public health response.

Frequently Asked Questions

What is the role of Nextclade in Lassa virus genomic surveillance?

Nextclade provides rapid lineage assignment and mutation calling for LASV sequences. It helps researchers distinguish Lassa virus from other mammarenaviruses and identify specific clades with high accuracy, which is essential for tracking the source and spread of outbreaks.

Why is the A76 mutation significant for Lassa fever clinical care?

The A76 mutation, prevalent in lineage II, is linked to reduced binding of certain monoclonal antibodies, such as 25.10C. Identifying this mutation through genomic surveillance helps clinicians understand potential treatment resistance and supports the development of broader immunotherapies.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Daodu RO et al. Lassa Virus Live Tracking and Lineage Assignment: How Nextstrain Can Enhance Surveillance and Public Health in Africa and Beyond. Emerg Microbes Infect. 2026 Mar 04. doi: 10.1080/22221751.2026.2640699. PMID: 41780060.

2. Nextstrain.org. New Resources for Rabies, Lassa, and Yellow Fever Virus. [Online]. Available from: https://nextstrain.org/ [Accessed March 2025].

3. PLOS. CLASV: Rapid Lassa virus lineage assignment with random forest. [Online]. Available from: https://journals.plos.org/ [Accessed March 2025].